AAPA Shines Light on Barriers to PA Practice and Opportunities to Improve Care in Multiple Comment Letters to Agencies

Over the last several weeks, AAPA submitted a series of comments to multiple agencies addressing topics ranging from anticompetitive practices against PAs to opportunities to improve policies in skilled nursing facilities, inpatient rehabilitation facilities, inpatient psychiatric facilities, and hospice. In addition, AAPA raised attention to regulatory and policy barriers that limit PA practice and impose administrative burdens in letters to HHS, CMS, FDA, and OMB.

AAPA Asks CMS to Remove Regulatory Restrictions on PAs Providing Hospice Care

In June 2025, AAPA submitted comments to the Centers for Medicare and Medicaid Services (CMS) regarding the topics of hospice, skilled nursing facilities, inpatient rehabilitation facilities, and inpatient psychiatric facilities. These comments, in response to annually released proposed rules that make adjustments to the hospice wage index and respective fee schedules, responded directly to inquiries made within the rules, as well as identified policy obstacles faced by PAs in these settings.

AAPA Submits Comments to DOJ and FTC Underscoring Anticompetitive Regulations Placing Barriers to PA Practice

In May 2025, AAPA submitted comments to the Department of Justice (DOJ) and the Federal Trade Commission (FTC) in response to separate, but similar, requests for information (RFIs) regarding the topic of anticompetitive laws and regulations at both the state and federal levels. These comments directly addressed inquiries made within the RFIs and identified obstacles faced by PAs due to anticompetitive measures.